Promising development for women with triple-negative breast cancer

[News]

Tamoxifen is a time-honored breast cancer drug used to treat millions of women with early-stage and less-aggressive disease, and now a University of Rochester Medical Center team has shown how to exploit tamoxifen's secondary activities so that it might work on more aggressive breast cancer.

More... (http://www.news-medical.net/news/20130424/Promising-development-for-women-with-triple-negative-breast-cancer.aspx)